GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $296,000 | +19.8% | 6,723 | +4.0% | 0.01% | +11.1% |
| Q3 2021 | $247,000 | -44.0% | 6,465 | -41.6% | 0.01% | -47.1% |
| Q2 2021 | $441,000 | +11.6% | 11,068 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $395,000 | -4.4% | 11,068 | -1.4% | 0.02% | -5.6% |
| Q4 2020 | $413,000 | -25.9% | 11,225 | -24.2% | 0.02% | -30.8% |
| Q3 2020 | $557,000 | -7.8% | 14,802 | 0.0% | 0.03% | -16.1% |
| Q2 2020 | $604,000 | +57.3% | 14,802 | +46.1% | 0.03% | +29.2% |
| Q1 2020 | $384,000 | -5.9% | 10,132 | +16.7% | 0.02% | +20.0% |
| Q4 2019 | $408,000 | +10.0% | 8,682 | 0.0% | 0.02% | 0.0% |
| Q3 2019 | $371,000 | +73.4% | 8,682 | +54.8% | 0.02% | +42.9% |
| Q4 2018 | $214,000 | -54.1% | 5,608 | -51.7% | 0.01% | -46.2% |
| Q3 2018 | $466,000 | -1.3% | 11,608 | -0.9% | 0.03% | -7.1% |
| Q2 2018 | $472,000 | +4.0% | 11,714 | +0.9% | 0.03% | +12.0% |
| Q1 2018 | $454,000 | +6.8% | 11,608 | -3.2% | 0.02% | +8.7% |
| Q4 2017 | $425,000 | -46.8% | 11,994 | -39.1% | 0.02% | -48.9% |
| Q3 2017 | $799,000 | +176.5% | 19,679 | +193.9% | 0.04% | +164.7% |
| Q2 2017 | $289,000 | -7.4% | 6,696 | -9.5% | 0.02% | -10.5% |
| Q1 2017 | $312,000 | -54.7% | 7,398 | -56.5% | 0.02% | -62.0% |
| Q1 2016 | $689,000 | -11.6% | 16,989 | -12.0% | 0.05% | -5.7% |
| Q4 2015 | $779,000 | -74.6% | 19,310 | -75.8% | 0.05% | -78.9% |
| Q3 2015 | $3,062,000 | -84.8% | 79,639 | -83.5% | 0.25% | -84.3% |
| Q2 2015 | $20,127,000 | -6.9% | 483,241 | +3.1% | 1.60% | -11.6% |
| Q1 2015 | $21,629,000 | +41.8% | 468,662 | +31.3% | 1.81% | +34.6% |
| Q4 2014 | $15,253,000 | -14.6% | 356,890 | -8.1% | 1.34% | -24.4% |
| Q3 2014 | $17,862,000 | -6.8% | 388,555 | +8.4% | 1.78% | -14.9% |
| Q2 2014 | $19,169,000 | +4.9% | 358,439 | +4.8% | 2.09% | -7.8% |
| Q1 2014 | $18,277,000 | +4.0% | 342,077 | +3.9% | 2.27% | -4.1% |
| Q4 2013 | $17,576,000 | +10.0% | 329,204 | +3.3% | 2.36% | -4.9% |
| Q3 2013 | $15,982,000 | +38.7% | 318,566 | +38.2% | 2.49% | +10.1% |
| Q2 2013 | $11,522,000 | – | 230,569 | – | 2.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |